Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results
Company is expected to release the results from the Phase I/II clinical trials this month
Reuters News - 6 hours ago
GlaxoSmithkline Plc
Also known as: GSK Last updated on: 06 June 2017
fast facts
Business SummaryManufacture of branded and generic drugs, chemicals, veterinary, vitamins and nutritional products; distribution of pharmaceutical productsCountry of IncorporationUnited KingdomOwnership TypePublicly ListedEstablished In1999Primary SectorHealth CareStock Listing| ID | Stock Type | Currency | Exchange | Symbol |
| GSK.F | Ordinary | GBP | Frankfurt SE | GSK |
Stock Performance Powered by Knowledge Direct
- 17.558
- -0.00
- -0.01%
- 17.538
- 17.56
- 17.36
- 4,245
- 2
- 73,960
- GBP 85,434M
Contact details
Primary address
Building: GlaxoSmithkline Plc BuildingStreet: Stockley Park West Street
Country: United Kingdom
City: Uxbridge
City Suffix: UB11 1BT
Region
MiddlesexCONTACT
- Tel: +44 20-8047-5000
- Tel: +44 20-8990-9000
- Fax: +44 20-8990-4321
- www.gsk.com
Officers
- Name availableChairman
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableDirector
- Name availableBoard Secretary
- Name availableChief Executive Officer
- Name availablePresident, Vaccines
- Name availablePresident, Consumer Healthcare
- Name availablePresident, Global Manufacturing and Supply
- Name availablePresident, Pharmaceuticals, Research and Development
- Name availableChief Financial Officer
- Name availableChief Strategy Officer
- Name availableSenior Vice President, Core Business Services and Chief Information Officer
- Name availableSenior Vice President and General Counsel
- Name availableSenior Vice President, Global Communications
- Name availableSenior Vice President, Goverance, Ethics and Assurance
- Name availableSenior Vice President, Human Resources
- Name availableHead of Rare Diseases Unit
- Name availableChairman, Global Research and Development and Vaccines
- Name availablePresident, Europe and EMAP
- Name availablePresident, Pharmaceuticals, North America
Related news
pharmaceutical
MoreCould COVID knock out flu in Europe this winter?
Social distancing, lockdowns help against flu viruses too
Reuters News - 01-Dec-2020French health body says nursing homes should get COVID-19 vaccine first
President Macron said vaccines could start to be administered as soon as the end of the year in France
Reuters News - 30-Nov-2020Medicago-GSK COVID-19 vaccine candidate to enter large human studies
The news comes days after the companies said the vaccine candidate produced virus-neutralizing antibodies in all volunteers
Reuters News - 12-Nov-2020GSK says flu shot shortage not linked to COVID-19 vaccine ramp up
A surge in demand for flu shots has led to shortages in some European cities
Reuters News - 11-Nov-2020Similar Companies
Find Out More Information
Access the most comprehensive database of companies and officers in the Middle East and North Africa, covering all major sectors and industries, from Refinitiv.
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Top News
Most Read
Find Companies
Zawya Coverage
Markets are recovering. Is it too late to buy?
Thursday Outlook: Gold rise to an over one-week high; oil prices drop
End of gold bull run? Further losses expected as vaccine hopes rise
Six key credit themes for global asset management sector in 2021
Wednesday Outlook: Dollar hovers near 2-1/2 year low; gold prices dip
Reuters Coverage
U.S. toughens visa rules for Chinese Communist Party members-State Department
Walmart to spend more than $700mln on new round of employee bonuses
Divers discover Nazi WW2 enigma machine in Baltic Sea
Delta Air expects daily cash burn of up to $14mln in fourth quarter
U.S.'s Khalilzad to Turkey, Qatar for talks on Afghanistan -State Dept